跳至主要内容
临床试验/NCT05314608
NCT05314608招募中不适用

Prospective Study of Bone Pathologies Resulting From Acute or Chronic Injury Treated With IntraOsseous BioPlasty® (IOBP®) Surgical Technique

Arthrex, Inc.5 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2021年11月17日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Arthrex, Inc.
入组人数
100
试验地点
5
主要终点
Prevention of additional surgery into the target knee

研究概览

简要总结

The study will be a prospective, multicenter clinical study evaluating clinical and patient reported outcome measures of subjects receiving IOBP® surgical technique using Angel cPRP and BMA processing system to treat subchondral bone pathology (SBP).

详细描述

The study will be a prospective, multicenter, clinical study, enrolling both male and female patients. Subjects will be identified among the investigators' patient population scheduled for the IOBP® procedure and as being diagnosed with symptomatic SBP that have failed conservative management. IRB approval will be obtained by each participating institution.

The primary outcome measure is adverse event evaluation to determine whether IOBP® can prevent further surgical intervention (i.e., knee replacement surgery, HTO, or calcium phosphate stabilization of SBP) when used to treat symptomatic SBP of the knee.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Able to read, understand, sign and complete informed consent
  • Male or female subject between the ages of 18-60 years
  • Subject has had pain for greater than three months
  • Subjects with single SBP in tibia or femur confirmed by minimum 1.5T MRI (including coronal, axial, sagittal, lateral femur, and lateral tibia views) and are candidates for an IOBP® procedure
  • Subject has stable ligaments
  • Subject has neutral alignment (max 5° varus or valgus)
  • Subject has a VAS score greater than or equal to five
  • Subject is scheduled to undergo surgical intervention using IOBP®

排除标准

  • Subject has diabetes Type I, Type II uncontrolled, or Type II insulin dependent
  • Subject has had lower extremity surgery within six months
  • Subject has had more than two prior surgical procedures in the operative leg
  • Subject has a neuromuscular condition
  • Subject has a current infection
  • Subject has a BMI >35
  • Subject has subchondral bone collapse or Kellgren Lawrence grade IV osteoarthritis
  • Subject has joint surface collapse in late stage avascular necrosis
  • Subject has majority of pain associated with alternate conditions
  • Subject has had subchondral bone pathology caused by acute trauma
  • Subject is not neurologically intact.
  • Subject has history of invasive malignancy (except non-melanoma skin cancer)
  • Subject that has a planned or scheduled additional surgery within the course of the study (lower extremity)
  • Subject has an active substance abuse problem
  • Subject is currently taking narcotic pain medication
  • Subject is pregnant or planning to become pregnant
  • Subject is on worker's compensation
  • Subject has a concomitant procedure not including meniscectomy, synovectomy, chondroplasty, or removal of loose body
  • Inability to complete study requirements and follow-up visits
  • Subject that has a bone marrow aspiration that does not meet 60cc

结局指标

主要结局

Prevention of additional surgery into the target knee

时间窗: 5 years

To evaluate if IOBP® procedure will prevent further surgical intervention (i.e., knee replacement surgery, HTO, or calcium phosphate stabilization of SBP) when used to treat symptomatic SBP of the knee.

次要结局

  • MRI of the knee(6 months and 1 year)
  • Knee Injury and Osteoarthritis Outcome Score (KOOS)(Collected at pre-op, 1 week post-op, 6 weeks post-op, 3 months post-op, 6 months post-op , 1 years post-op , 2 years post-op, 3 years post-op , 4 years post-op and 5 years post-op)
  • International Knee Documentation Committee Subjective Knee Evaluation Form(knee-specific instrument, developed to assess the patients' opinion about their knee and associated problems. The KOOS evaluates both short-term and long-term consequences of knee injury.)
  • Visual Analog Pain Scale (VAS)(Collected at pre-op, 1 week post-op, 6 weeks post-op, 3 months post-op, 6 months post-op , 1 years post-op , 2 years post-op, 3 years post-op , 4 years post-op and 5 years post-op.)
  • X-rays of the knee(6 months and 1 year)

研究者

发起方
Arthrex, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验